Why Is Zimmer Biomet Stock Trading Lower On Thursday?
1. ZBH reported Q4 EPS of $2.31, beating estimates. 2. Sales reached $2.02 billion, up 4.3% year-over-year. 3. Knee and hip product sales rose, reflecting strong demand. 4. ZBH's acquisition of Paragon 28 aims to diversify its portfolio. 5. 2025 EPS guidance is below consensus, projecting slower growth.